Literature DB >> 1612481

Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease.

M H Giaffer1, C D Holdsworth, B I Duerden.   

Abstract

Escherichia coli strains cultured from 74 patients with inflammatory bowel disease at different stages of disease activity (Crohn's disease (40), ulcerative colitis (34)) and 18 healthy controls were studied in relation to haemolysin and verotoxin production and enteroadherence. Disease activity was assessed by standard clinical and laboratory tests. Haemolytic E coli were isolated from 18% of patients with Crohn's disease, 24% with ulcerative colitis, and 11% of healthy controls. None of these differences was significant. No verotoxin producing strains were detected among the 216 E coli isolates examined but the extract from five strains (Crohn's (4), ulcerative colitis (1) produced a distinctive cytopathic effort on Vero cell monolayers which was later shown not to be due to verotoxin. The adhesion indices of E coli isolates cultured were: mean (SEM) 42.2 (6.4) for Crohn's disease, 43.3 (6.2) for ulcerative colitis, and 11.3 (2.0) for normal controls (p less than or equal to 0.0001). Adhesive E coli were isolated from 62% of patients with Crohn's disease and 68% with ulcerative colitis but from only 6% of normal controls (p less than or equal to 0.0002). Neither haemolysin production nor enteroadherence was dependent upon disease activity, disease location, sulphasalazine treatment, or previous intestinal resection. These results indicate that only enteroadherent E coli were frequently associated with inflammatory bowel disease; their relation to the pathogenesis of these conditions, however, remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612481      PMCID: PMC1379295          DOI: 10.1136/gut.33.5.646

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

2.  Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease.

Authors:  M H Giaffer; G North; C D Holdsworth
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

3.  Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea.

Authors:  D A Burke; A T Axon
Journal:  BMJ       Date:  1988-07-09

4.  Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors.

Authors:  I Ofek; D Mirelman; N Sharon
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

5.  Ulcerative colitis and Escherichia coli with adhesive properties.

Authors:  D A Burke; A T Axon
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

6.  From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on enteropathogenic Escherichia coli.

Authors:  R Edelman; M M Levine
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

7.  Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock.

Authors:  A Donohue-Rolfe; G T Keusch
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

8.  Models for studying the adhesion of enterobacteria to the mucosa of the human intestinal tract.

Authors:  D C Candy; T S Leung; A D Phillips; J T Harries; W C Marshall
Journal:  Ciba Found Symp       Date:  1981

9.  Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis.

Authors:  R J Dickinson; S A Varian; A T Axon; E M Cooke
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

Review 10.  Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.

Authors:  M M Levine
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

View more
  34 in total

1.  Activation of NF-kappaB in intestinal epithelial cells by E. coli strains isolated from the colonic mucosa of IBD patients.

Authors:  Katia La Ferla; Dirk Seegert; Stefan Schreiber
Journal:  Int J Colorectal Dis       Date:  2004-04-22       Impact factor: 2.571

Review 2.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

3.  The role of the immune system in regulating the microbiota.

Authors:  Benjamin P Willing; Navkiran Gill; B Brett Finlay
Journal:  Gut Microbes       Date:  2010-03-04

Review 4.  Escherichia coli and ulcerative colitis.

Authors:  D Burke
Journal:  J R Soc Med       Date:  1997-11       Impact factor: 5.344

5.  Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls.

Authors:  C Schultsz; M Moussa; R van Ketel; G N Tytgat; J Dankert
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

6.  Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis.

Authors:  T Ohkusa; I Okayasu; T Ogihara; K Morita; M Ogawa; N Sato
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 7.  Infectious etiopathogenesis of Crohn's disease.

Authors:  Jessica Carrière; Arlette Darfeuille-Michaud; Hang Thi Thu Nguyen
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 8.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 10.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.